Eric L. Dobmeier

2013

In 2013, Eric L. Dobmeier earned a total compensation of $2.3M as Chief Operating Officer at Seattle Genetics, a 6% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$260,804
Option Awards$865,543
Salary$456,258
Stock Awards$738,720
Other$8,130
Total$2,329,455

Dobmeier received $865.5K in option awards, accounting for 37% of the total pay in 2013.

Dobmeier also received $260.8K in non-equity incentive plan, $456.3K in salary, $738.7K in stock awards and $8.1K in other compensation.

Rankings

In 2013, Eric L. Dobmeier's compensation ranked 3,361st out of 12,286 executives tracked by ExecPay. In other words, Dobmeier earned more than 72.6% of executives.

ClassificationRankingPercentile
All
3,361
out of 12,286
73rd
Division
Manufacturing
1,135
out of 4,612
75th
Major group
Chemicals And Allied Products
301
out of 1,462
79th
Industry group
Drugs
205
out of 1,156
82nd
Industry
Biological Products, Except Diagnostic Substances
29
out of 196
85th
Source: SEC filing on April 6, 2016.

Dobmeier's colleagues

We found five more compensation records of executives who worked with Eric L. Dobmeier at Seattle Genetics in 2013.

2013

Clay Siegall

Seattle Genetics

Chief Executive Officer

2013

Jonathan Drachman

Seattle Genetics

Chief Medical Officer

2013

Todd Simpson

Seattle Genetics

Chief Financial Officer

2013

Vaughn Himes

Seattle Genetics

EVP, Technical Operations

2013

Christopher Boerner

Seattle Genetics

Former EVP, Commercial

You may also like